AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Proposed Australian trial eyes up blood testing for Alzheimer's

Utilising networks of GPs across three states, a large-scale study intends on combining digital...

Applications open for $300K pandemic therapeutics fellowships

Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...

CTA granted for CAR-T cell therapy for multiple myeloma

The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...

Content from other channels on our network

Mitigating unseen losses in large food packs

Perfect Automation and Omori have joined forces with packaging solutions

Fonterra names Richard Allen as new CEO

Food packaging testing supports Atlantic crossing victory

Seprify and BIOGRUND develop titanium dioxide-free tablet coating for nutraceuticals

Call for 10c increase on container return schemes

Water transition key at Global Water Summit 2026

CCEP Australia strengthens producer responsibility

Veolia ANZ appoints new CEO

Map reveals hidden UV risk for next-gen solar panels

Ensuring reliable level measurement in tanks with internal obstructions

Australia and US investing in additional critical minerals projects

How to centralise remote access: securing all access to your OT systems

Shining a light on cyber threats hiding on the plant floor

AI system learns to keep warehouse robot traffic running smoothly